The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

19951,469 citationsJournal Articlebronze Open Access

Authors

Munther A. Khamashta

María José Cuadrado

F Mujić

Nick Taub · St. Thomas Hospital

Beverley J. Hunt

Graham R.V. Hughes

Abstract

The risk of recurrent thrombosis in patients with the antiphospholipid-antibody syndrome is high. Long-term anticoagulation therapy in which the international normalized ratio is maintained at or above 3 is advisable in these patients.

Topics & Keywords

Systemic Lupus Erythematosus Research Blood disorders and treatments Platelet Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 332, Issue 15, pp. 993-997

DOI: 10.1056/nejm199504133321504

Field-Weighted Citation Impact: 69.22